Daniel W. Muehl, See Remarks at Clovis Oncology, Inc. (CLVS), sold 2,506 shares at $5.92 ($15K) on 2020-08-03, disclosed to the SEC on 2020-08-05.
Seasonal sale ($15k) by See Remarks — this insider has traded CLVS in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.92 | 1,139 | $7K | 45.5% |
| 2 | $5.92 | 1,367 | $8K | 54.5% |
| Total | $5.92 avg | 2,506 | $15K | 100% |
| Filing → |
| CLVS | SELL | 2022-08-03 | $7K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $9K | — | Filing → |